These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

804 related items for PubMed ID: 17158768

  • 1. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
    Baradari V, Huether A, Höpfner M, Schuppan D, Scherübl H.
    Endocr Relat Cancer; 2006 Dec; 13(4):1237-50. PubMed ID: 17158768
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

  • 3. SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines.
    Ryu JK, Lee WJ, Lee KH, Hwang JH, Kim YT, Yoon YB, Kim CY.
    Cancer Lett; 2006 Jun 08; 237(1):143-54. PubMed ID: 16009488
    [Abstract] [Full Text] [Related]

  • 4. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.
    Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5271-81. PubMed ID: 15297431
    [Abstract] [Full Text] [Related]

  • 5. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours.
    Höpfner M, Baradari V, Huether A, Schöfl C, Scherübl H.
    Endocr Relat Cancer; 2006 Mar 01; 13(1):135-49. PubMed ID: 16601284
    [Abstract] [Full Text] [Related]

  • 6. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M, Premkumar DR, Arnold B, Pollack IF.
    J Neurosurg; 2005 Dec 01; 103(6 Suppl):549-56. PubMed ID: 16383255
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines.
    Sakajiri S, Kumagai T, Kawamata N, Saitoh T, Said JW, Koeffler HP.
    Exp Hematol; 2005 Jan 01; 33(1):53-61. PubMed ID: 15661398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR, Almenara JA, Grant S.
    Cancer Res; 2003 Jul 01; 63(13):3637-45. PubMed ID: 12839953
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K, Saatcioglu F.
    Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787
    [Abstract] [Full Text] [Related]

  • 11. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 15; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 12. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun 15; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH.
    Int J Oncol; 2005 Aug 15; 27(2):473-9. PubMed ID: 16010430
    [Abstract] [Full Text] [Related]

  • 14. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors.
    Fournel M, Trachy-Bourget MC, Yan PT, Kalita A, Bonfils C, Beaulieu C, Frechette S, Leit S, Abou-Khalil E, Woo SH, Delorme D, MacLeod AR, Besterman JM, Li Z.
    Cancer Res; 2002 Aug 01; 62(15):4325-30. PubMed ID: 12154036
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS, Cho NY, Kim HR, Tsurumi T, Jang YS, Lee WK, Lee SK.
    Oncol Rep; 2008 Jan 01; 19(1):93-8. PubMed ID: 18097580
    [Abstract] [Full Text] [Related]

  • 16. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells.
    Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P.
    Br J Haematol; 2010 May 01; 149(4):518-28. PubMed ID: 20201941
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells.
    Woo HJ, Lee SJ, Choi BT, Park YM, Choi YH.
    Exp Mol Pathol; 2007 Feb 01; 82(1):77-84. PubMed ID: 16574101
    [Abstract] [Full Text] [Related]

  • 18. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
    Romanski A, Bacic B, Bug G, Pfeifer H, Gul H, Remiszewski S, Hoelzer D, Atadja P, Ruthardt M, Ottmann OG.
    Haematologica; 2004 Apr 01; 89(4):419-26. PubMed ID: 15075075
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL, Van Quill KR, O'Brien JM.
    Clin Cancer Res; 2008 May 15; 14(10):3113-23. PubMed ID: 18483379
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.